| Title: | Chemical inhibition of MrkH-dependent activation of type 3 fimbriae synthesis and biofilm formation by Klebsiella pneumoniae |
| Authors: | Wilksch, JJ Tan, JWH Nero, TL Hocking, DM Bennett-Wood, V Wang, NY Zavras, SA Schiesser, CH Tauschek, M Schembri, MA Lithgow, T Hartland, EL Robins-Browne, RM Parker, MW Yang, J Strugnell, RA |
| Issue Year: | 2025 |
| Publisher | NATURE PORTFOLIO |
| Series | NPJ BIOFILMS AND MICROBIOMES: |
| Abstract | Biofilm formation by Klebsiella pneumoniae is mediated by the type 3 fimbriae Mrk, and regulated by MrkH and 3',5'-cyclic diguanylic acid (c-di-GMP). We sought to identify specific chemical inhibitors of K. pneumoniae biofilm formation that reduced the activity of MrkH. A compound N-(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thien-2-yl)-2-methoxybenzamide, JT71, reduced K. pneumoniae mrkA promoter activity and biofilm formation by 50% without affecting cell viability. Western blot analysis, hemagglutination assays, electron microscopy and qPCR showed that JT71 reduced type 3 fimbriae production, and transcription of mrkA and mrkH. JT71 demonstrated activity against other clinical and multi-drug resistant K. pneumoniae isolates, and a type 3 fimbriate-positive Citrobacter koseri strain. In silico molecule docking was used to illustrate that JT71 could bind directly to the MrkH protein and block its activity. JT71 possesses promising drug-likeness properties and is non-toxic to mammalian cells. Chemical inhibition of transcriptional regulators that control fimbriae expression can inhibit bacterial biofilm formation. |
| URI: | https://publications.svi.edu.au/publications/10375 |
| Other Identifiers | 10.1038/s41522-025-00834-3 |
| Publication type | Article |